Study on medical treatment for patients with reflux esophagitis refractory to proton pump inhibitor - Treatment for patients with reflux esophagitis refractory to proton pump inhibitor

Department of Gastroenterology, Kobe University Hospital0 个研究点目标入组 50 人开始时间: 2010年7月20日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Patients with the past history of digestive tract excisio and vagotomy (2) Patients who have alert symptoms such as nausea, gastrointestinal bleeding and rapid weight loss (3) Patients who have past history of or suffer from the following diseases: Zollinger-Ellison symdrome, inflammatory bowel disease, esophageal stenosis, achalasia, malabsorption, cerebrovascular disease such as cerebral hemorrhage or cerebral infarction (4) Patients having severe liver, kidney or heart disease (5) Patients who have malignancy or are suspected of having malignancy (6) Patients who are pregnant, in breast-feeding or may have cecome pregnant (7) Patients who need continuous medication of atazanavir sulfate, diazepam, phenytoin, warfarin, tacrolimus, digoxin, methyldigoxin, itraconazole, Gefinitinib or voriconazole that might interact with the test drug (8) Patients who are receiving proton pump inhibitors except rabeprazole (9) Patients whom the doctor in charge judged to be unsuitable as an object of this study

发起方

Department of Gastroenterology, Kobe University Hospital